Carregant...
HER2 amplification and HER2 mutation are distinct molecular targets in lung cancers
INTRODUCTION: Human epidermal growth factor receptor 2 (HER2, ERBB2) alterations have been identified as oncogenic drivers and potential therapeutic targets in lung cancers. The molecular associations of HER2 gene amplification, mutation, and HER2 protein overexpression in lung cancers have not been...
Guardat en:
| Publicat a: | J Thorac Oncol |
|---|---|
| Autors principals: | , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4698879/ https://ncbi.nlm.nih.gov/pubmed/26723242 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jtho.2015.10.025 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|